Ladiratuzumab vedotin, CAS [[1629760-29-7]]

Produktübersicht

• Artikelname: Ladiratuzumab vedotin, CAS [[1629760-29-7]]
• Artikelnummer: TGM-T9901A-044
• Hersteller Artikelnummer: T9901A-044
• Alternativnummer: TGM-T9901A-044-1MG,TGM-T9901A-044-5MG,TGM-T9901A-044-10MG
• Hersteller: TargetMol
• Kategorie: Biochemikalien
• Alternative Synonym: SGN-LIV1A

Produktbeschreibung

Ladiratuzumab vedotin (SGN-LIV1A) is an ADC (IC 50: 5.6 nM for LIV-1) that targets LIV-1. This compound is composed of a humanized IgG1 monoclonal antibody, linked to MMAE via a protease-cleavable linker. It induces immunogenic cell death (ICD), which triggers an immune response. Ladiratuzumab vedotin is utilized in breast cancer research [1] [2] [3] [4].

Produkteigenschaften

• Reinheit: 95.00%
• CAS Nummer: [1629760-29-7]
• Target-Kategorie: Antibody-Drug Conjugates (ADCs)